PD63-03 UTILITY OF BLUE LIGHT FLEXIBLE CYSTOSCOPY FOR BLADDER CANCER SURVEILLANCE AFTER INTRAVESICAL THERAPY

Overview of attention for article published in The Journal of Urology, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 12 news stories from 12 outlets.

OSLO, Norway, Sept. 15, 2021 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces a clinical data…

OSLO, Norway, Sept. 15, 2021 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces a clinical data…

"These new study results also highlight the range of opportunities made possible by Blue Light Cystoscopy for urologists, and…

OSLO, Norway, Sept. 15, 2021 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces a clinical data…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 8 additional news stories.